Elliott Winton, MD
- Professor of Hematology & Medical Oncology, Emory University School of Medicine
Sponsored Research Projects
- A Phase 3, Randomized, Double-blind Active-controlled Study Evaluating Momelotinib vs. Ruxolitinib in Subjects With Primary Myelofibrosis (PMF) or Post-Polycythemia Vera or Post-Essential Thrombocythemia Myelofibrosis (Post-PV/ET MF)
- GS-US-352-1214 A Phase 3, Randomized Study To Evaluate the Efficacy of Momelotinib
Program Topics
Affiliated Units
- Emory University School of Medicine